- Featured HTB 2024: latest news online 3 January 2024. Related: Editorial.
- Almost 1 in 5 people in Switzerland disconnected from HIV care over 10 years: only half reconnected and with advanced infection 22 January 2025. Related: Special reports, Treatment strategies.
- BHIVA pregnancy guidelines online for comment: deadline 25 January 20 January 2025. Related: Pregnancy, Guidelines.
- Detailed results from Palm007 study: no clinical impact of tecovirimat against mpox clade 1 6 January 2025. Related: mpox (monkeypox), IDWeek 2024.
- Tecovirimat news continues: Japan approval includes mpox indication 2 January 2025. Related: mpox (monkeypox).
- Looking back through 2024 and forward to 2025… 1 January 2025. Related: Special reports.
- i-Base appeal: Q&A services and the website in 2025 1 January 2025. Related: Editorial, Special reports.
- Future meetings and webinars 2025 1 January 2025. Related: Future meetings.
- ART pipeline 2025: exciting dual long-acting combinations and the challenge of generic dolutegravir 1 January 2025. Related: Special reports, Conference reports, Pipeline report, Antiretrovirals, HIV 17 Glasgow 2024.
- Transient impact of lenacapavir against MDR HIV-2 without other active ART 1 January 2025. Related: Antiretrovirals, Treatment strategies, Virology, Drug resistance.
- Lenacapavir submitted to the US FDA with an indication for HIV PrEP 1 January 2025. Related: Antiretrovirals, Treatment access, HIV prevention and transmission.
- Chiva short films on children and HIV shortlisted for charity award 12 December 2024. Related: Paediatric care, Treatment advocacy, On the web.
- HIVR4P 2024 conference resources now open access 12 December 2024. Related: Conference reports, On the web, R4P 2024 Lima.
- Tecovirimat fails to show benefit in randomised STOMP study in mpox clade 2 10 December 2024. Related: mpox (monkeypox), Other news.
- IAS-USA 2024 guidelines for HIV treatment and prevention: some differences to EACS and UK 5 December 2024. Related: Guidelines.
- i-Base guides updated online 5 December 2024. Related: Editorial, Early access.
- HTB news: i-Base changes during 2024 1 December 2024. Related: Editorial, Special reports.
- Glasgow HIV Congress 2024: Introduction and links 26 November 2024. Related: Conference reports, HIV 17 Glasgow 2024, Conference index.
- Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48 26 November 2024. Related: Conference reports, Antiretrovirals, HIV 17 Glasgow 2024.
- EACS guidelines: New format and contents includes chemsex 26 November 2024. Related: Conference reports, Guidelines, HIV 17 Glasgow 2024.
- Double dose start for oral PrEP in new EACS guidelines – rapid protection in two hours 26 November 2024. Related: Conference reports, Guidelines, HIV prevention and transmission, HIV 17 Glasgow 2024.
- Future PrEP and new results on lenacapavir from PURPOSE 1 and 2 – does HIV exposure explain incident cases? 26 November 2024. Related: Conference reports, HIV prevention and transmission, HIV 17 Glasgow 2024.
- Liverpool University Drug Interaction website recognised for global impact on research and care 26 November 2024. Related: Conference reports, PK and drug interactions, Treatment advocacy, HIV 17 Glasgow 2024.
- HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure 26 November 2024. Related: Conference reports, Hepatitis coinfection, HIV 17 Glasgow 2024.
- Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000 21 November 2024. Related: Conference reports, Antiretrovirals, HIV 17 Glasgow 2024.
- Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan 9 November 2024. Related: Special reports, Book and film reviews.
- WHO toolkit to strengthen engagement of health workers in emergency responses 5 November 2024. Related: On the web.
- Bipolar disorder in people living with HIV 1 November 2024. Related: Coinfections and complications.
- Mpox breakthrough cases after two doses of the MVA-BN vaccine 1 November 2024. Related: mpox (monkeypox).
- Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic 1 November 2024. Related: Treatment access, Paediatric care, Drug resistance.
- Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA 23 October 2024. Related: mpox (monkeypox).
- Helsinki Declaration: 2024 edition upholds ethical access to treatment 23 October 2024. Related: Treatment access, HIV prevention and transmission.
- Lack of tecovirimat activity against mpox clade 1 21 October 2024. Related: mpox (monkeypox), Coinfections and complications.
- Efficacy of MVA-BN vaccine: systematic review 21 October 2024. Related: mpox (monkeypox).
- Kidney transplants from HIV positive donors to HIV recipients 17 October 2024. Related: Coinfections and complications, Cancer and HIV.
- US NIAID updates HIV guide to person-centred language 17 October 2024. Related: Treatment advocacy, Book and film reviews, On the web.
- Long COVID essentials: link to online resources 15 October 2024. Related: On the web, COVID-19.
- HIVR4P 2024: Introduction 14 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, Conference index, R4P 2024 Lima.
- Urgency of planning broad vaccine-like access to lenacapavir PrEP globally 13 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, R4P 2024 Lima.
- Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound 9 October 2024. Related: Conference reports, Antiretrovirals, HIV prevention and transmission, R4P 2024 Lima.
- Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study 9 October 2024. Related: Conference reports, HIV prevention and transmission, R4P 2024 Lima.
- HIVR4P 2024: Context of PrEP in Latin America 7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, R4P 2024 Lima.
- HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care 6 October 2024. Related: Special reports.
- Mpox outbreak in Australia: half of cases had previously received a vaccine 3 October 2024. Related: mpox (monkeypox).
- Gilead announces plans to support generic lenacapavir for low-income countries 2 October 2024. Related: Treatment access.
- WHO situation report on mpox 2 October 2024. Related: mpox (monkeypox).
- Major update of UK PrEP guidelines online for public consultation 1 October 2024. Related: Special reports, Guidelines, HIV prevention and transmission.
- NICE defers decision on CAB-LA as PrEP needing more information 27 September 2024. Related: Treatment access, HIV prevention and transmission.
- Second lenacapavir PrEP study protected 99.9% of people in the PURPOSE 2 trial: ACT UP London challenge pricing 26 September 2024. Related: HIV prevention and transmission.
- UNAIDS reports debt crisis obstructs HIV response 19 September 2024. Related: Treatment access, Other news.
- i-Base library archived at the Bishopsgate Institute and Wellcome Collection 17 September 2024. Related: Treatment advocacy, Other news.
